Nitric oxide-induced perturbations in a cell culture model of the blood-brain barrier.
The actions of an intracellular nitric oxide generator compound on the properties of a co-culture model of the blood-brain barrier are described. Addition of the iron-sulphur cluster nitrosyl Roussin's black salt (RBS, heptanitrosyl-tri-mu3-thioxotetraferrate (1-)) resulted in a rapid and dose-dependent (50-250 microM) decline in the electrical resistance displayed by co-cultures of vascular endothelial cells and C6 glioma cells. The breach in barrier integrity elicited by RBS (250 microM) could be prevented by either haemoglobin (100 microM), methylene blue (200 microM), or by photon-induced inactivation of RBS. In contrast, the nitric oxide synthase inhibitor nitro-L-arginine methyl ester (250 microM) caused no inhibition in the decline in resistance of RBS-exposed cultures. Addition of 8-bromo-guanosine-cyclic monophosphate (500 microM) did not mimic the actions of RBS. Exposure to intense light of co-cultures manifesting a high transcellular electrical resistance resulted in a reduction in tissue resistance which could be prevented by the presence of haemoglobin (100 microM). We conclude that nitric oxide liberated from RBS results in a reversible diminution in the integrity of the endothelial cell barrier in the co-culture system, and we suggest that light-sensitive endogenous nitric oxide generator compounds may be present in intact cells. Possible roles of nitric oxide in blood-brain-barrier function are considered.
Hurst
R D
RD
Department of Cellular Physiology, The Babraham Institute, Cambridge, U.K.
Fritz
I B
IB
D000818:Animals; D001812:Blood-Brain Barrier / Q000187:drug effects*; D017097:Electric Impedance; D004730:Endothelium, Vascular / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism; D005910:Glioma / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D007365:Intercellular Junctions / Q000187:drug effects; D007502:Iron Chelating Agents / Q000494:pharmacology*; D058085:Iron Compounds; D009569:Nitric Oxide / Q000378:metabolism*; D009603:Nitroso Compounds; D051381:Rats; D014665:Vasodilator Agents / Q000494:pharmacology*
D007502:Iron Chelating Agents; D058085:Iron Compounds; D009603:Nitroso Compounds; D014665:Vasodilator Agents; D009569:Nitric Oxide; C078952:Roussin's Black Salt